Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
Abstract Background Detecting carcinoma prostate (CaP) after intravesical Bacillus Calmette Guerin (BCG) immunotherapy for non‐muscle invasive bladder cancer (NMIBC) poses diagnostic challenges. Granulomatous prostatitis (GP) has an incidence of 0.8%–3.3% in post‐intravesical BCG patients and 6% inc...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-11-01
|
Series: | BJUI Compass |
Subjects: | |
Online Access: | https://doi.org/10.1002/bco2.446 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|